Viewing StudyNCT00121836



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00121836
Status: COMPLETED
Last Update Posted: 2011-04-27
First Post: 2005-07-18

Brief Title: A Study of Xeloda Capecitabine in Women With HER2-Negative Metastatic Breast Cancer
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2008-12
Primary Completion Date Type: ACTUAL
Completion Date: 2008-12
Completion Date Type: ACTUAL
First Submit Date: 2005-07-18
First Submit QC Date: July 18 2005
Study First Post Date: 2005-07-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-03-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-04-25
Last Update Post Date: 2011-04-27
Last Update Post Date Type: ESTIMATED